Harvard Bioscience (HBIO) Assets Average (2011 - 2026)
Harvard Bioscience (HBIO) posted quarterly Assets Average of $79.0 million for Q1 2026, down 23.46% year-over-year from $103.2 million in Q1 2025, and little changed quarter-over-quarter from $79.0 million in Q4 2025.
Harvard Bioscience (HBIO) Assets Average (2011 - 2026) Analysis & Trends
Harvard Bioscience (HBIO) has reported Assets Average for 16 consecutive years, with $79.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Assets Average fell 23.46% year-over-year to $79.0 million; the TTM figure through Mar 2026 stood at $79.0 million (down 23.46% YoY), while the FY2025 annual figure was $103.4 million, down 21.7% from the prior year.
- Assets Average steadied at $79.0 million in Q1 2026 per HBIO's latest filing, from $79.0 million in the prior quarter.
- Across five years, Assets Average topped out at $160.2 million in Q1 2022 and bottomed at $79.0 million in Q1 2026.
- Historically, Assets Average has averaged $125.3 million across 5 years, with a median of $135.3 million in 2024.
- Annual changes were most pronounced in 2022 — Assets Average increased 4.19% — and 2025, when it sank 39.23%.
- Harvard Bioscience's Assets Average stood at $146.2 million in 2022, then dropped by 5.22% to $138.6 million in 2023, then retreated by 6.94% to $128.9 million in 2024, then plunged by 38.71% to $79.0 million in 2025, then fell by 0.03% to $79.0 million in 2026.
- Business Quant data shows HBIO's Assets Average at $79.0 million in Q1 2026, $79.0 million in Q4 2025, and $79.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 20.49 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 50.78 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 31.36 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 8.88 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 39.18 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 4.09 Bn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 14.17 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 12.45 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 19.82 Bn |
| 10 | Harvard Bioscience | 34.12 Mn | 27.61 Mn | 12.63 Mn | 77.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 77.11 Mn |
| Mar 31, 2026 | 79.00 Mn |
| Dec 31, 2025 | 79.03 Mn |
| Sep 30, 2025 | 79.04 Mn |
| Jun 30, 2025 | 79.95 Mn |
| Mar 31, 2025 | 103.22 Mn |
| Dec 31, 2024 | 128.94 Mn |
| Sep 30, 2024 | 130.08 Mn |
| Jun 30, 2024 | 131.04 Mn |
| Mar 31, 2024 | 135.26 Mn |
| Dec 31, 2023 | 138.55 Mn |
| Sep 30, 2023 | 141.32 Mn |
| Jun 30, 2023 | 144.24 Mn |
| Mar 31, 2023 | 145.47 Mn |
| Dec 31, 2022 | 146.19 Mn |
| Sep 30, 2022 | 151.14 Mn |
| Jun 30, 2022 | 156.66 Mn |
| Mar 31, 2022 | 160.19 Mn |
| Dec 31, 2021 | 158.11 Mn |
| Sep 30, 2021 | 153.92 Mn |